DalsnaFinance

B-Cell Depletion Therapy Market to Reach USD 62.6 Billion by 2036, Growing at an 8.9% CAGR as Next-Generation Immunotherapy Adoption Accelerates

Markets PR Newswire By PR Newswire 09 Jul 2026 14:01 1 min read
B-Cell Depletion Therapy Market to Reach USD 62.6 Billion by 2036, Growing at an 8.9% CAGR as Next-Generation Immunotherapy Adoption Accelerates

NEWARK, Del., July 9, 2026 /PRNewswire/ -- According to the latest market analysis by Future Market Insights, the global B-Cell Depletion Therapy Market is projected to grow from USD 26.7 billion in 2026 to USD 62.6 billion by 2036, registering a CAGR of 8.9% during the forecast period....

NEWARK, Del., July 9, 2026 /PRNewswire/ -- According to the latest market analysis by Future Market Insights, the global B-Cell Depletion Therapy Market is projected to grow from USD 26.7 billion in 2026 to USD 62.6 billion by 2036, registering a CAGR of 8.9% during the forecast period....

Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.